| Cho, Jae Yong |
| Active, not recruiting | 3 | 450 | Europe, Japan, US, RoW | Regorafenib, Stivarga, Nivolumab, Opdivo, Docetaxel, Taxotere, Paclitaxel, Abraxane, Irinotecan, Camptosar, Trifluridine/Tipracil, Lonsurf | Australasian Gastro-Intestinal Trials Group, Bayer, Bristol-Myers Squibb, University of Sydney, Academic and Community Cancer Research United, Taiwanese Cooperative Oncology Group, Frankfurter Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest, National Cancer Center Hospital East, Syneos Health | Gastro-Oesophageal Cancer | 06/25 | 06/26 | | |
| Recruiting | 2/3 | 400 | US | Nectero EAST System | Nectero Medical, Inc. | Abdominal Aortic Aneurysm | 03/27 | 12/29 | | |
| Terminated | 2 | 205 | Europe, US, RoW | ladiratuzumab vedotin, SGN-LIV1A, pembrolizumab, Keytruda | Seagen Inc., Merck Sharp & Dohme LLC | Small Cell Lung Cancer, Non-small Cell Lung Cancer, Squamous, Non-small Cell Lung Cancer, Non-squamous, Head and Neck Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Prostate Cancer, Melanoma | 11/23 | 11/23 | | |
| Active, not recruiting | 1/2 | 300 | US, RoW | CAB-AXL-ADC, PD-1 inhibitor | BioAtla, Inc. | Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma | 01/25 | 01/25 | | |
VISION, NCT04151615: VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma |
|
|
| Completed | N/A | 203 | RoW | | Boryung Pharmaceutical Co., Ltd | Multiple Myeloma | 01/23 | 01/23 | | |
| Recruiting | N/A | 110 | US, RoW | NEXUS Aortic Stent Graft System | Endospan Ltd. | Aortic Dissection, Aortic Aneurysm, Intramural Hematoma, Penetrating Aortic Ulcer | 11/24 | 10/29 | | |
NCT05053295: Investigator-initiated Pilot Study to Investigate the Efficacy and Safety of Immuncell-LC in Combination With Nivolumab (Opdivo) in Subjects With Advanced or Recurrent Gastric Cancer |
|
|
| Recruiting | N/A | 20 | RoW | autologous activated T lymphocyte, Immuncell-LC (Autologous activated T lymphocyte), | Gangnam Severance Hospital | Relapsed or Advanced Gastric Adenocarcinoma, Gastro-esophageal Junction Cancer | 07/23 | 09/23 | | |
| Recruiting | N/A | 550 | Europe, Japan, US, RoW | Medtronic Endurant II or Endurant IIs Stent Graft System, Gore Excluder or Gore/ Excluder Conformable AAA Endoprosthesis | Medtronic Cardiovascular | Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder) | 05/27 | 05/31 | | |
| Recruiting | N/A | 2000 | Europe, Canada, US | Gelsoft Plus Vascular Graft, Gelsoft Plus, Vascular Bypass Graft, Gelsoft Plus Extra Anatomical, Cardiovascular Patch, Gelseal Patch, Gelsoft Patch, Thinwall Patch, Cardiovascular Fabrics, Gelweave Vascular Graft, Gelweave, Gelweave Valsalva Vascular Graft, Gelweave Valsalva | Vascutek Ltd. | Aneurysm, Dissection, Aortic Root Aneurysm, Aortic Root Dissection, Carotid Artery Injuries, Aortic Arch, Bypass Extremity Graft, Occlusive Vascular Disease, Aortic Diseases | 01/26 | 01/33 | | |
ASSIST, NCT05529459: Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD |
|
|
| Recruiting | N/A | 2400 | RoW | Percutaneous Coronary Intervention | Seung-Whan Lee, M.D., Ph.D., Biotronik Korea Co., Ltd | Coronary Disease | 12/26 | 07/30 | | |
| Kashyap, Vikram |
CREST-H, NCT03121209: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics |
|
|
| Active, not recruiting | 3 | 385 | Canada, US | Revascularization, Intensive Medical Management (IMM) alone | Columbia University, National Institute of Neurological Disorders and Stroke (NINDS), Mayo Clinic, University of Alabama at Birmingham, University of Maryland, University of California, Los Angeles | Internal Carotid Artery Stenosis, Cognitive Impairment | 01/27 | 07/27 | | |
ROADSTER 3, NCT05365490: Post-approval Study of Transcarotid Artery Revascularization in Standard Risk Patients with Significant Carotid Artery Disease |
|
|
| Active, not recruiting | N/A | 344 | US | Transcarotid Artery Revascularization (TCAR), Carotid Revascularization, Carotid Artery Stenting | Silk Road Medical | Carotid Artery Diseases | 09/25 | 09/25 | | |
CREST-2, NCT02089217: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial |
|
|
| Active, not recruiting | N/A | 2486 | Europe, Canada, US, RoW | Carotid endarterectomy (CEA), Carotid Stenting (CAS), Intensive Medical Management - no CEA, Intensive Medical Management - no CAS | Thomas G. Brott, M.D., National Institute of Neurological Disorders and Stroke (NINDS) | Carotid Stenosis | 02/26 | 02/26 | | |
| Bejar, Rafael |
NCT03893682: A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas |
|
|
| Active, not recruiting | 1 | 160 | US | CG-806, Luxeptinib | Aptose Biosciences Inc. | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Non-Hodgkin's Lymphoma | 12/24 | 05/25 | | |
NCT04477291: A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS |
|
|
| Active, not recruiting | 1 | 80 | US | CG-806 | Aptose Biosciences Inc. | Acute Myeloid Leukemia, Myelodysplastic Syndromes | 12/24 | 05/25 | | |
| Onders, Raymond |
ERAS, NCT04899856: Randomized Study of TransAeris® System in Cardiac Surgery Patients at Risk of Prolonged Mechanical Ventilation |
|
|
| Active, not recruiting | N/A | 40 | US | TransAeris | Synapse Biomedical | Ventilator Induced Diaphragm Dysfunction | 05/24 | 05/24 | | |
| Leshnower, Bradley |
| Recruiting | N/A | 110 | US, RoW | NEXUS Aortic Stent Graft System | Endospan Ltd. | Aortic Dissection, Aortic Aneurysm, Intramural Hematoma, Penetrating Aortic Ulcer | 11/24 | 10/29 | | |
| Active, not recruiting | N/A | 30 | US | penetrating atherosclerotic ulcer, aorta branch cardiovascular implant, Relay Branch System, system, endovascular graft, aortic aneurysm treatment | Bolton Medical | Thoracic Aorta Aneurysm, Aneurysm, Ruptured, Aortic Aneurysm | 09/23 | 08/28 | | |
| Active, not recruiting | N/A | 115 | US | AMDS | Artivion Inc., Syneos Health | Acute Aortic Dissection | 12/23 | 12/29 | | |
| Shishehbor, Medhi |
TAP-DANCE, NCT03942601: Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization |
|
|
| Terminated | 2 | 10 | US | Temsirolimus, Temsirolimus and dexamethasone sodium phosphate | Mercator MedSystems, Inc. | Peripheral Arterial Disease | 04/21 | 04/21 | | |
| Kinder, Carla |
CREST-H, NCT03121209: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics |
|
|
| Active, not recruiting | 3 | 385 | Canada, US | Revascularization, Intensive Medical Management (IMM) alone | Columbia University, National Institute of Neurological Disorders and Stroke (NINDS), Mayo Clinic, University of Alabama at Birmingham, University of Maryland, University of California, Los Angeles | Internal Carotid Artery Stenosis, Cognitive Impairment | 01/27 | 07/27 | | |
| Bennett, Janelle |
TAP-DANCE, NCT03942601: Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization |
|
|
| Terminated | 2 | 10 | US | Temsirolimus, Temsirolimus and dexamethasone sodium phosphate | Mercator MedSystems, Inc. | Peripheral Arterial Disease | 04/21 | 04/21 | | |
| Kane, Donna |
NCT05319028: Study of Mivavotinib (CB-659) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) |
|
|
| Terminated | 2 | 2 | US | Mivavotinib, CB-659 | Calithera Biosciences, Inc | Non-GCB/ABC Diffuse Large B-Cell Lymphoma, With and Without MyD88 and/or CD79B Mutations | 02/23 | 02/23 | | |
| Elgudin, Yakov |
| Recruiting | N/A | 110 | US, RoW | NEXUS Aortic Stent Graft System | Endospan Ltd. | Aortic Dissection, Aortic Aneurysm, Intramural Hematoma, Penetrating Aortic Ulcer | 11/24 | 10/29 | | |
| Buerki, Robin |
| Recruiting | 1 | 18 | US | 186RNL, Rhenium-186 NanoLiposome | Plus Therapeutics | Leptomeningeal Metastasis | 12/25 | 06/26 | | |
FORESEE, NCT05414123: A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide |
|
|
| Terminated | N/A | 40 | US | CNSide | Biocept, Inc., ICON plc | Leptomeningeal Metastasis, Leptomeningeal Disease, Leptomeningeal Neoplasms, Breast Cancer, Non-Small Cell Lung Cancer | 10/23 | 10/23 | | |
| Lambert, Simon |
NCT04921865: Case Series on the Clinical Performance of VA Clavicle and Clavicle Hook Plate 2.7 Systems |
|
|
| Recruiting | N/A | 76 | Europe, US | DPS VA-LCP® Clavicle Plate 2.7 System; DPS VA-LCP® Clavicle Hook Plate 2.7 System | AO Innovation Translation Center | Clavicle, Acromioclavicular Joint, Fracture | 01/27 | 09/29 | | |
| Ochenjele, George |
| Recruiting | N/A | 300 | US | CERAMENT BVF | BONESUPPORT AB | Orthopedic Disorder | 03/25 | 03/25 | | |
NCT04921865: Case Series on the Clinical Performance of VA Clavicle and Clavicle Hook Plate 2.7 Systems |
|
|
| Recruiting | N/A | 76 | Europe, US | DPS VA-LCP® Clavicle Plate 2.7 System; DPS VA-LCP® Clavicle Hook Plate 2.7 System | AO Innovation Translation Center | Clavicle, Acromioclavicular Joint, Fracture | 01/27 | 09/29 | | |
| Recruiting | N/A | 100 | US | CERAMENT G | BONESUPPORT AB | Chronic Osteomyelitis, Fracture Related Infection, Diabetic Foot Osteomyelitis | 09/28 | 09/28 | | |
| Walker, Valerie |
REITAB-2, NCT05204563: Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, ) |
|
|
| Recruiting | 3 | 450 | Europe, US, RoW | Combination of Imipenem/Cilastatin and XNW4107, Imipenem/Cilastatin/Relebactam, Recarbrio | Evopoint Biosciences Inc. | Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia | 04/25 | 12/25 | | |
| Active, not recruiting | 2 | 42 | US | Drug: RT234 - vardenafil inhalation powder; Device: Axially Oscillating Sphere dry powder inhaler (AOS DPI), inhaled vardenafil | Respira Therapeutics, Inc. | Pulmonary Arterial Hypertension | 11/24 | 12/24 | | |
| Mitchell, Sarah |
| Recruiting | N/A | 110 | US, RoW | NEXUS Aortic Stent Graft System | Endospan Ltd. | Aortic Dissection, Aortic Aneurysm, Intramural Hematoma, Penetrating Aortic Ulcer | 11/24 | 10/29 | | |
| Kolackzo, Jensen |
NCT04921865: Case Series on the Clinical Performance of VA Clavicle and Clavicle Hook Plate 2.7 Systems |
|
|
| Recruiting | N/A | 76 | Europe, US | DPS VA-LCP® Clavicle Plate 2.7 System; DPS VA-LCP® Clavicle Hook Plate 2.7 System | AO Innovation Translation Center | Clavicle, Acromioclavicular Joint, Fracture | 01/27 | 09/29 | | |
| Almaguel |
| Recruiting | 3 | 430 | US, RoW | 177Lu-TLX591, Lutetium (177Lu) rosopatamab tetraxetan, Enzalutamide, Abiraterone, Docetaxel | Telix Pharmaceuticals (Innovations) Pty Limited | Metastatic Castration-resistant Prostate Cancer | 12/27 | 12/30 | | |
